The Clorox Company $CLX Position Lessened by Morningstar Investment Management LLC

Morningstar Investment Management LLC reduced its stake in shares of The Clorox Company (NYSE:CLX) by 44.7% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 34,539 shares of the company’s stock after selling 27,915 shares during the quarter. Morningstar Investment Management LLC’s holdings in Clorox were worth $3,579,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in CLX. Compound Planning Inc. increased its holdings in shares of Clorox by 15.4% in the 1st quarter. Compound Planning Inc. now owns 2,451 shares of the company’s stock worth $254,000 after acquiring an additional 328 shares during the period. Dickmeyer Boyce Financial Management Inc. acquired a new position in Clorox during the 1st quarter valued at about $456,000. Sei Investments Co. boosted its stake in Clorox by 21.1% during the 1st quarter. Sei Investments Co. now owns 59,425 shares of the company’s stock valued at $6,157,000 after purchasing an additional 10,373 shares during the period. Lido Advisors LLC grew its position in Clorox by 31.4% in the 1st quarter. Lido Advisors LLC now owns 12,975 shares of the company’s stock worth $1,345,000 after purchasing an additional 3,104 shares during the last quarter. Finally, Cetera Investment Advisers increased its stake in shares of Clorox by 44.5% in the first quarter. Cetera Investment Advisers now owns 105,704 shares of the company’s stock valued at $10,954,000 after purchasing an additional 32,539 shares during the period. 78.53% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on CLX shares. JPMorgan Chase & Co. reduced their price objective on Clorox from $95.00 to $92.00 and set an “underweight” rating for the company in a research report on Thursday, July 16th. Zacks Research cut Clorox from a “hold” rating to a “strong sell” rating in a research report on Tuesday, May 12th. Morgan Stanley reduced their price target on Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research report on Friday, May 1st. The Goldman Sachs Group reissued a “sell” rating and issued a $83.00 price target on shares of Clorox in a research note on Friday, May 1st. Finally, Wells Fargo & Company lowered their price target on Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a report on Monday, May 18th. One analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have given a Sell rating to the company’s stock. Based on data from MarketBeat, Clorox currently has a consensus rating of “Reduce” and a consensus target price of $102.80.

Insiders Place Their Bets

In other news, Director Pierre R. Breber bought 5,000 shares of the stock in a transaction that occurred on Tuesday, May 5th. The shares were purchased at an average cost of $85.82 per share, with a total value of $429,100.00. Following the completion of the acquisition, the director directly owned 18,000 shares in the company, valued at approximately $1,544,760. The trade was a 38.46% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.63% of the stock is owned by corporate insiders.

Clorox Price Performance

Shares of NYSE:CLX opened at $95.61 on Friday. The stock has a market cap of $11.56 billion, a price-to-earnings ratio of 15.52 and a beta of 0.54. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The Clorox Company has a 12 month low of $84.70 and a 12 month high of $131.86. The stock’s 50 day moving average price is $95.10 and its 200 day moving average price is $103.83.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The company had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same period last year, the firm earned $1.45 EPS. The firm’s revenue for the quarter was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities research analysts anticipate that The Clorox Company will post 5.52 earnings per share for the current fiscal year.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.